Cheng R, Lim J, Fortuna M, Reyes Jr D, Hans E, Nellas R
Sci Rep. 2025; 15(1):7052.
PMID: 40016249
PMC: 11868416.
DOI: 10.1038/s41598-025-85153-5.
Isakovic S, Sencanski M, Perovic V, Stevanovic K, Prodic I
Life (Basel). 2025; 15(2).
PMID: 40003571
PMC: 11856470.
DOI: 10.3390/life15020162.
Neander L, Hannemann C, Netz R, Sahoo A
JACS Au. 2025; 5(1):204-216.
PMID: 39886596
PMC: 11775700.
DOI: 10.1021/jacsau.4c00886.
Furnon W, Cowton V, De Lorenzo G, Orton R, Herder V, Cantoni D
Nat Microbiol. 2025; 10(1):77-93.
PMID: 39753670
PMC: 11726466.
DOI: 10.1038/s41564-024-01878-5.
Hwang W, Austin S, Blondel A, Boittier E, Boresch S, Buck M
J Phys Chem B. 2024; 128(41):9976-10042.
PMID: 39303207
PMC: 11492285.
DOI: 10.1021/acs.jpcb.4c04100.
Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition.
Asor R, Olerinyova A, Burnap S, Kushwah M, Soltermann F, Rudden L
Proc Natl Acad Sci U S A. 2024; 121(40):e2403260121.
PMID: 39298475
PMC: 11459207.
DOI: 10.1073/pnas.2403260121.
The Malaria Box molecules: a source for targeting the RBD and NTD cryptic pocket of the spike glycoprotein in SARS-CoV-2.
Otazu K, Olivos-Ramirez G, Fernandez-Silva P, Vilca-Quispe J, Vega-Chozo K, Jimenez-Avalos G
J Mol Model. 2024; 30(7):217.
PMID: 38888748
DOI: 10.1007/s00894-024-06006-y.
Single domain antibodies from camelids in the treatment of microbial infections.
De Greve H, Fioravanti A
Front Immunol. 2024; 15:1334829.
PMID: 38827746
PMC: 11140111.
DOI: 10.3389/fimmu.2024.1334829.
Cancer cells and viruses share common glycoepitopes: exciting opportunities toward combined treatments.
Roy R
Front Immunol. 2024; 15:1292588.
PMID: 38495885
PMC: 10940920.
DOI: 10.3389/fimmu.2024.1292588.
Inclusion of deuterated glycopeptides provides increased sequence coverage in hydrogen/deuterium exchange mass spectrometry analysis of SARS-CoV-2 spike glycoprotein.
Haynes C, Keppel T, Mekonnen B, Osman S, Zhou Y, Woolfitt A
Rapid Commun Mass Spectrom. 2024; 38(5):e9690.
PMID: 38355883
PMC: 10871554.
DOI: 10.1002/rcm.9690.
Unraveling viral drug targets: a deep learning-based approach for the identification of potential binding sites.
Popov P, Kalinin R, Buslaev P, Kozlovskii I, Zaretckii M, Karlov D
Brief Bioinform. 2023; 25(1).
PMID: 38113077
PMC: 10783863.
DOI: 10.1093/bib/bbad459.
Complementary Pocket and Network-Based Approach to Search for Spike Protein Allosteric Pocket Sites.
Cheng R, Quirante J, Vargas L, Gatchalian A, Nellas R
ACS Omega. 2023; 8(48):45313-45325.
PMID: 38075758
PMC: 10701870.
DOI: 10.1021/acsomega.3c04007.
Inconspicuous Yet Indispensable: The Coronavirus Spike Transmembrane Domain.
Aliper E, Efremov R
Int J Mol Sci. 2023; 24(22).
PMID: 38003610
PMC: 10671605.
DOI: 10.3390/ijms242216421.
Structural insights into the modulation of coronavirus spike tilting and infectivity by hinge glycans.
Chmielewski D, Wilson E, Pintilie G, Zhao P, Chen M, Schmid M
Nat Commun. 2023; 14(1):7175.
PMID: 37935678
PMC: 10630519.
DOI: 10.1038/s41467-023-42836-9.
Structure adaptation in Omicron SARS-CoV-2/hACE2: Biophysical origins of evolutionary driving forces.
Hsiao Y, Bray D, Taddese T, Jimenez-Serratos G, Crain J
Biophys J. 2023; 122(20):4057-4067.
PMID: 37717145
PMC: 10624932.
DOI: 10.1016/j.bpj.2023.09.003.
Docking and Molecular Dynamics Simulations Clarify Binding Sites for Interactions of Novel Marine Sulfated Glycans with SARS-CoV-2 Spike Glycoprotein.
Samanta P, Mishra S, Pomin V, Doerksen R
Molecules. 2023; 28(17).
PMID: 37687244
PMC: 10490367.
DOI: 10.3390/molecules28176413.
The SARS-CoV-2 Spike Protein Mutation Explorer: using an interactive application to improve the public understanding of SARS-CoV-2 variants of concern.
Iannucci S, Harvey W, Hughes J, Robertson D, Poyade M, Hutchinson E
J Vis Commun Med. 2023; 46(3):122-132.
PMID: 37526402
PMC: 10726978.
DOI: 10.1080/17453054.2023.2237087.
SARS-CoV-2 uses CD4 to infect T helper lymphocytes.
Brunetti N, Davanzo G, de Moraes D, Ferrari A, Souza G, Muraro S
Elife. 2023; 12.
PMID: 37523305
PMC: 10390044.
DOI: 10.7554/eLife.84790.
Identification of Potential Lead Compounds Targeting Novel Druggable Cavity of SARS-CoV-2 Spike Trimer by Molecular Dynamics Simulations.
Zhao Y, Zhao Y, Xie L, Li Q, Zhang Y, Zang Y
Int J Mol Sci. 2023; 24(7).
PMID: 37047254
PMC: 10094189.
DOI: 10.3390/ijms24076281.
CHARMM-GUI : Past, Current, and Future Developments and Applications.
Feng S, Park S, Choi Y, Im W
J Chem Theory Comput. 2023; 19(8):2161-2185.
PMID: 37014931
PMC: 10174225.
DOI: 10.1021/acs.jctc.2c01246.